These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G. Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623 [Abstract] [Full Text] [Related]
6. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis. Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G. Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337 [Abstract] [Full Text] [Related]
8. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis. Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH. Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782 [Abstract] [Full Text] [Related]
9. [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting]. Eszlinger M, Neustadt M, Ruschenburg I, Neumann A, Franzius C, Adam S, Bacher K, Hach A, Hammoser R, Langvogt C, Molwitz T, Paschke R. Dtsch Med Wochenschr; 2014 Mar; 139(10):476-80. PubMed ID: 24570192 [Abstract] [Full Text] [Related]
15. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV. Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068 [Abstract] [Full Text] [Related]
16. BRAF V600 co-testing is technically feasible in conventional thyroid fine needle aspiration (FNA) cytology smears and can reduce the need for completion thyroidectomy. Poller DN, Glaysher S. Cytopathology; 2014 Jun; 25(3):155-9. PubMed ID: 24164374 [Abstract] [Full Text] [Related]
17. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [Abstract] [Full Text] [Related]
18. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation. Kwon HJ, Kim EK, Kwak JY. Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369 [Abstract] [Full Text] [Related]
20. VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases. Lee SR, Yim H, Han JH, Lee KB, Lee J, Soh EY, Kim DJ, Chung YS, Jeong SY, Sheen SS, Park SH, Kim JH. Am J Clin Pathol; 2015 Mar; 143(3):437-44. PubMed ID: 25696803 [Abstract] [Full Text] [Related] Page: [Next] [New Search]